tradmap

ELDN Earnings Eledon Pharmaceuticals, Inc.

Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated

Annual results

Diluted EPS (annual)
-$6 -$3 $0 2021 2022 2023 2024 2025
EPS
Revenue (annual)
$0 $1 $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Revenue
Net income (annual)
-$117M -$58M $0 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Net income

Quarterly results

Diluted EPS (quarterly)
-$4 -$2 $0 Q3 '22 Q2 '23 Q1 '24 Q3 '24 Q2 '25 Q1 '26
EPS
Net income (quarterly)
-$45M $16M $77M $0 Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
Net income
Return on equity (quarterly)
-96% 141% 378% 0% Q3 '23 Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26
ROE

Reported EPS history

1–21 of 21
Q2 20262026-06-30-0.592026-08-1310-Q
Q1 20262026-03-31-0.332026-05-1310-Q
FY 20252025-12-31-0.522026-03-1910-K
Q3 20252025-09-30-0.422025-11-1410-Q
Q2 20262025-06-30-0.212026-08-1310-Q
Q1 20262025-03-31-0.082026-05-1310-Q
FY 20252024-12-31-0.662026-03-1910-K
Q3 20252024-09-30-1.232025-11-1410-Q
Q2 20252024-06-30-1.612025-08-1410-Q
Q1 20252024-03-31-0.792025-05-1410-Q
FY 20242023-12-31-4.732025-03-2010-K
Q3 20242023-09-30-3.792024-11-1210-Q
Q2 20242023-06-30-3.992024-08-1910-Q
Q1 20242023-03-31-0.752024-05-1510-Q
FY 20232022-12-31-6.162024-03-2810-K
Q3 20232022-09-30-2.072023-11-0910-Q
Q2 20232022-06-30-1.342023-08-1010-Q
Q1 20232022-03-31-0.692023-05-1110-Q
FY 20222021-12-31-2.332023-03-3010-K
Q3 20222021-09-30-1.732022-11-1410-Q
Q2 20222021-06-30-1.072022-08-1110-Q

Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.